Fujifilm research into COVID-19 drug spills into June, dashing hope of May approval
Research into Fujifilm Holdings Corp's Avigan will continue into June, Japan's government said on Tuesday, effectively dashing hopes by Prime Minister Shinzo Abe that the drug would be approved as a COVID-19 treatment this month.
from Reuters: Health News https://reut.rs/2XsNPj3
https://bit.ly/2zwRqiM
May 25, 2020
|
Labels:
health,
Reuters: Health News
|
This entry was posted on May 25, 2020
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.